Stem Cell Umbilical Cord Blood Forecast Report – Designed for Decision Makers and Product Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Stem Cell Umbilical Cord Blood Market?
The market size of stem cell umbilical cord blood has seen a significant increase in the past few years. The market, which was valued at $6.77 billion in 2024, is estimated to grow to $7.98 billion in 2025, with a compound annual growth rate (CAGR) of 17.8%. Factors like escalated research and development activities, higher demand for private banking services, an increase in the number of clinical trials, a rise in cancer incidents, and the growth of fertility clinics, have contributed to the historical growth.
What Growth Rate Is Forecasted for the Stem Cell Umbilical Cord Blood Market by 2029?
In the coming years, the stem cell umbilical cord blood market is projected to experience swift expansion, reaching a valuation of $15.21 billion in 2029 with a compound annual growth rate (CAGR) of 17.5%. This surge within the forecast period can be associated with the growing incidence of chronic illnesses, rise in childbirth rates, heightened demand for stem cell treatments, increasingly positive government policies and initiatives, and a stronger focus on regenerative medicine. Among the significant trends anticipated during this forecast period are advancements in therapeutic applications and cryopreservation techniques, superior healthcare infrastructures, and the fusion of this market with gene therapy.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24715&type=smp
Which Key Companies Are Shaping the Future of the Stem Cell Umbilical Cord Blood Market?
Major companies operating in the stem cell umbilical cord blood market are Takeda Pharmaceutical Company Limited, Global Cord Blood Corporation, Vita 34 AG, Cordlife Group Limited, StemLife Berhad, MediPost Co. Ltd., Smart Cells International Ltd., StemCyte Inc., Celularity Inc., Next Biosciences Pty Ltd, Esperite N.V., Cryo-Cell International Inc., FamiCord Group, Cells4Life Group LLP, Cryoviva Biotech Pvt. Ltd., Americord Registry LLC, ViaCord LLC, China Cord Blood Corporation, CBR Systems Inc., Cord Blood Registry.
Which Factors Are Driving Demand in the Stem Cell Umbilical Cord Blood Industry?
The rise in childbirth rates is anticipated to stimulate the expansion of the stem cell umbilical cord blood market. This rate is defined as the count of live births per 1,000 individuals within a specific population over a particular period, typically a year. This surge in childbirth rates can be attributed to the wider accessibility and affordability of fertility treatments, allowing for an increase in family expansion. Umbilical cord blood stem cells are highly sought after for newborns given their content of hematopoietic stem cells, which can serve as treatments for various blood, immune, and genetic conditions. These cells provide a flawless genetic match for the infant and can potentially benefit siblings or relatives. For example, as reported by the U.S. Centers for Disease Control and Prevention, a federal agency in the U.S., there was an upwards shift from 3,596,017 births in 2023 to 3,622,673 in 2024 in the USA, reflecting a 1% increase. Thus, the surge in childbirth rates is fueling the expansion of the stem cell umbilical cord blood market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=24715&type=smp
How Is the Stem Cell Umbilical Cord Blood Market Segmented by Several Divisions?
The stem cell umbilical cord blood market covered in this report is segmented –
1) By Product Type: Cord Blood Stem Cells, Cord Tissue Stem Cells
2) By Technology: Cryopreservation, Stem Cell Expansion, Cell Separation
3) By Storage Services: Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks
4) By Application: Hematological Disorders, Metabolic Diseases, Immune System Disorders, Neurological Disorders, Other Applications
5) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users
Subsegments:
1) By Cord Blood Stem Cells: Hematopoietic Stem Cells, Mesenchymal Stem Cells, Endothelial Progenitor Cells, Regulatory T Cells, Natural Killer Cells, Dendritic Cells
2) By Cord Tissue Stem Cells: Mesenchymal Stem Cells, Epithelial Cells, Fibroblasts, Neural Progenitor Cells
What are the Emerging Market Trends Driving the Growth of the Stem Cell Umbilical Cord Blood Industry?
Leading companies in the stem cell umbilical cord blood market are making strides in creating innovative treatments and gaining associated approvals, such as cord blood cell therapy. This therapy is used to address uncommon genetic disorders, bolster immune system recovery, and aid in regenerative medicine applications. It involves harnessing stem cells found in umbilical cord blood to regenerate or repair blood, immune, and other tissue systems damaged by different diseases. For example, in October 2024, StemCyte, a biotechnology company based in the United States, was granted the regenerative medicine advanced therapy designation by the U.S. Food and Drug Administration (FDA). This designation pertained to their hematopoietic progenitor cell cord blood therapy (HPC Cord Blood) for tackling Long COVID-19 syndrome. This cord blood cell therapy makes use of stem cells taken from umbilical cord blood to stimulate healing and mitigate inflammation. It has demonstrated potential in managing immune-associated and degenerative conditions, providing a non-invasive and ethically sourced alternative for advancing regenerative treatments.
Access The Full Report Here:
Which Regions Are Driving Growth in the Stem Cell Umbilical Cord Blood Market?
North America was the largest region in the stem cell umbilical cord blood market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell umbilical cord blood market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24715
This Report Delivers Insight On:
1. How big is the stem cell umbilical cord blood market, and how is it changing globally?
2. Who are the major companies in the stem cell umbilical cord blood market, and how are they performing?
3. What are the key opportunities and risks in the stem cell umbilical cord blood market right now?
4. Which products or customer segments are growing the most in the stem cell umbilical cord blood market?
5. What factors are helping or slowing down the growth of the stem cell umbilical cord blood market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
